Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples